Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
347.00    5.00 (1.46%)
Bid:
345.00
Ask:
347.00
Spread: 2.00 (0.58%)
Market Cap: £3.43b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Potential Transaction

16 Feb 2026 09:41

RNS Number : 1644T
Rosebank Industries PLC
16 February 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

 

FOR IMMEDIATE RELEASE

 

16 February 2026

 

 

Rosebank Industries plc

Potential Transaction

 

Further to the recent press speculation, Rosebank Industries plc ("Rosebank" or the "Company") confirms that it is in advanced discussions regarding the potential acquisition of two private equity-owned US-based businesses (the "Potential Transaction") for a headline enterprise value of approximately $3.05 billion.

Rosebank notes that the Potential Transaction is in line with the Company's acquisition criteria and, if it proceeds, would be funded through a combination of a fully underwritten equity issue of approximately £1.9 billion (the "Fundraise") and new debt facilities. The Fundraise would be executed by way of a firm placing concurrent with a retail offer of up to £10 million for UK retail shareholders and investors.

The Company confirms that, irrespective of whether the Potential Transaction proceeds or not, it intends to complete its move to the Main Market of the London Stock Exchange in Q2 2026.

Temporary suspension of trading

As per AIM Rule 40, dealings in the Company's ordinary shares have been temporarily suspended from trading on AIM with immediate effect until such time as the MTF admission prospectus in relation to the Potential Transaction has been published in compliance with AIM Rule 14. If the Potential Transaction does not proceed and an MTF admission prospectus has not been published, an announcement will be made and the suspension from trading of Rosebank ordinary shares will be lifted.

Notwithstanding the temporary suspension of trading in the ordinary shares, the Company will continue to make announcements as and when there are any developments that require announcement under the AIM Rules.

Enquiries:

 

Rosebank

Via Montfort Communications

Simon Peckham, Chief Executive

Matthew Richards, Group Finance Director

www.rosebankindustries.com

 

Montfort Communications

+44 7739 701 634 / +44 7921 881 800

Nick Miles, Charlotte McMullen

miles@montfort.london/mcmullen@montfort.london

Investec Bank plc (Nominated Adviser)

Carlton Nelson, Christopher Baird

 

About Rosebank

 

Rosebank was established in 2024 to acquire businesses whose performance the Directors believe can be improved so as to create shareholder value. Rosebank's strategy is to acquire quality industrial or manufacturing businesses with strong fundamentals whose performance may be improved. Through investing in acquired businesses, changing management focus and delivering operational improvements, Rosebank seeks to increase and realise the value in such businesses, typically over a three-to-five-year investment horizon and to return the proceeds to shareholders. Rosebank was admitted to trading on the AIM Market of the London Stock Exchange, through an Initial Public Offering in July 2024.

 

Important Notices:

 

This announcement is released by Rosebank Industries plc and contains inside information. The person responsible for arranging for the release of this announcement on behalf of Rosebank is Joff Crawford.

 

There can be no certainty that any potential transaction contemplated in this announcement will proceed. For the avoidance of doubt, the issue of this announcement shall not, in any circumstances, create any implication that Rosebank Industries plc shall be required to provide further updates on the status of any matters contemplated in this announcement (save as may be required by law or regulation).

 

Any securities offered will not be or have not been registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 

Investec Bank plc ("Investec"), which is authorised in the United Kingdom by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for Rosebank and no one else in connection with the Potential Transaction and none of Investec Bank plc nor any of its affiliates, branches or subsidiaries will be responsible to anyone other than Rosebank for providing the protections afforded to clients of Investec Bank plc nor for providing advice in relation to the Potential Transaction or any other matter referred to in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTFMLTMTJBMPF
Date   Source Headline
31st Dec 20191:00 pmRNSTotal Voting Rights
3rd Dec 201912:27 pmRNSIssue of Equity and change to TVR
29th Nov 20195:00 pmRNSTotal Voting Rights
22nd Nov 20194:52 pmRNSHolding(s) in Company
21st Nov 201912:43 pmRNSResult of General Meeting and change to TVR
14th Nov 20192:10 pmRNSHolding(s) in Company
8th Nov 20194:12 pmRNSHolding(s) in Company
4th Nov 20192:16 pmRNSDirector/PDMR shareholding
4th Nov 20197:05 amRNSIssue of equity and notice of general meeting
4th Nov 20197:00 amRNSProposed Acquisition-McCoy Interest & Fundraising
14th Oct 20197:00 amRNSRestructuring of the Paradox project
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSDirectorate Changes and Board Restructuring
2nd Sep 201910:59 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
22nd Aug 20197:00 amRNSIssue of equity and change to total voting rights
30th Jul 201912:46 pmRNSResult of AGM and update on Board composition
10th Jul 20193:01 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSBoard appointment and update
28th Jun 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSNotice of Annual Results
3rd Jun 20197:00 amRNSTotal Voting Rights
24th May 20197:00 amRNSSubscription completion, board appointment & TVR
20th May 20197:00 amRNSIssue of equity and Board Changes
30th Apr 20197:00 amRNSUpdated Corporate Presentation
23rd Apr 20197:00 amRNSDirectorate Change
12th Apr 20193:40 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSIssue of equity and Board Changes
28th Mar 20197:00 amRNSUpdate & Proposed Board Changes
26th Mar 20199:41 amRNSHolding in Company - Correction
12th Mar 20194:17 pmRNSHolding(s) in Company
5th Mar 20196:09 pmRNSHolding(s) in Company
5th Mar 20199:12 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSAcquisition of additional acreage in Paradox Basin
7th Jan 20197:00 amRNSSchlumberger Study Results
6th Dec 20187:00 amRNSOperations Update
27th Nov 20187:00 amRNSDatabase Agreement & North Wash Vanadium update
1st Nov 20187:00 amRNSBLM Approval for Permit to Drill GV 22-1 well
3rd Oct 20187:00 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
18th Jul 20181:46 pmRNSHolding(s) in Company
18th Jul 20181:44 pmRNSHolding(s) in Company
3rd Jul 20181:47 pmRNSCantor Fitzgerald initiates research coverage
28th Jun 201811:28 amRNSResult of AGM
28th Jun 20187:00 amRNSInterviews with CEO Matthew Idiens
22nd Jun 20187:00 amRNSCPR - Maiden Contingent Resource and NPV Estimate
19th Jun 20187:00 amRNSAppointment of Financial Adviser and Joint Broker
14th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSFinal Results & notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.